Redalsomatropin alfa
Redalsomatropin alfa (JR-142) is a recombinant long-acting growth hormone. Redalsomatropin alfa extends its half-life through fusion with modified serum albumin. Redalsomatropin alfa is well-tolerated and can maintain IGF-1 levels. Redalsomatropin alfa can be used in research related to growth hormone deficiency[1].
Product Specifications
CAS Number
2793441-31-1
Product Name Alternative
JR-142
UNSPSC
12352203
Target
GHR; IGF-1R
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/redalsomatropin-alfa.html
Smiles
[Redalsomatropinalfa]
References & Citations
[1]Owada Y, et al. Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study. Growth Horm IGF Res. 2022 Dec;67:101500.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041820-100 1x 100 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472173-500 1x 500 µL
Catenin, beta (CTNNB1) (rCTNNB1/2173), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472598-500 1x 500 µL
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681422-100 1x 100 µL
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (NX2/1422R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details